The Trump administration’s 2025 drug policy agenda omits cannabis rescheduling, despite earlier signals of support, instead prioritizing fentanyl, border security, and addiction treatment. This omission, coupled with a...more
6/9/2025
/ Biden Administration ,
Cannabis Products ,
DEA ,
Department of Justice (DOJ) ,
Legislative Agendas ,
Marijuana ,
New Legislation ,
Opioid ,
Proposed Legislation ,
Regulatory Reform ,
Trump Administration